Total Funding
55
45
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
65911
Abcam helps researches with breakthroughs in areas such as cancer, neurological disorders, infectious diseases, and metabolic disorders.
Acquired by 
Danaher
Jac Price: SVP, Supply Chain & ManufacturingPast Role: Beckman Coulter, Sr. Vice President , Global Operations
Tony Kouzarides: Co-Founder
Danaher
About the Company
Abcam helps researches with breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.
